Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Research Associate

Biomedical Sciences · India · 2023-01-12

Processing Time
93 days
Decision Date
2023-01-12
Location
North Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue investigating the underlying pathology of herpesviruses to develop therapeutic intervention strategies that minimize the prevalence and severity of these diseases. Her work specifically focuses on human cytomegalovirus (HCMV), which affects 60% to 90% of the human population, to design novel prevention and treatment strategies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses HCMV, a condition infecting a vast majority of the human race and millions of Americans, representing a clear national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a Ph.D., 11 peer-reviewed articles, 149 citations, and seven years of direct research experience in herpesvirus pathology.

3 Waiver Benefit Met

The medical community's urgent need for novel HCMV strategies and the petitioner's unique insights make waiving the labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the researcher's Ph.D. and 7 years of specialized experience, supported by 11 peer-reviewed journal articles and 2 book chapters. Her work earned 149 citations and was backed by 4 expert recommendation letters, satisfying all three Dhanasar prongs by addressing a disease affecting millions of Americans.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 5 days 2024-07-30
The petitioner proposes to continue researching viral pathogenesis and host-virus interactions to unravel the mechanisms of viral replication, transmission, and pathogenesis. This work aims to design vaccines, antiviral drugs, and diagnostic tools to combat viral threats and mitigate pandemics.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 591 days 2025-11-27
The petitioner proposes to continue her research in biomedical science, specifically focusing on uncovering the mechanisms of disease-causing viruses and tuberculosis to identify how they operate and can be more effectively treated. Her work involves investigating viral mechanisms, immune responses, and therapeutic pathways to develop novel antiviral treatments and nonviral delivery platforms.
View Case

Research Fellow

Biotechnology · Estonia

WeGreened EB-2 (NIW) approved
Maryland 36 days 2025-05-09
The petitioner proposes to continue her research in the field of biomedical sciences, specifically focusing on the development and characterization of antiviral therapeutics. She utilizes advanced molecular virology, multi-omics, and immune profiling techniques to unravel complex virus-host interactions. Her work aims to inform the creation of novel treatment approaches and improve existing virus mitigation strategies to enhance public health resilience.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 93 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist